Brief: Radiopharm Theranostics Ltd Co Partners With Starpharma On Research And Option Agreement To Develop Novel Radiotherapy Asset
30/09/2025 11:17
Sept 30 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RADIOPHARM THERANOSTICS LTD: CO PARTNERS WITH STARPHARMA ON RESEARCH AND OPTION AGREEMENT TO DEVELOP NOVEL RADIOTHERAPY ASSET Source text: [ID:n0001213900-25-093349] Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising